- Home
- TNGX vs LINC Comparison
TNGX vs LINC Comparison
Compare TNGX & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- LINC
- Stock Information
- Founded
- TNGX 2014
- LINC 1946
- Country
- TNGX United States
- LINC United States
- Employees
- TNGX N/A
- LINC N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- LINC Other Consumer Services
- Sector
- TNGX Health Care
- LINC Real Estate
- Exchange
- TNGX Nasdaq
- LINC Nasdaq
- Market Cap
- TNGX 723.0M
- LINC 729.2M
- IPO Year
- TNGX N/A
- LINC 2005
- Fundamental
- Price
- TNGX $6.53
- LINC $23.04
- Analyst Decision
- TNGX Strong Buy
- LINC Strong Buy
- Analyst Count
- TNGX 5
- LINC 4
- Target Price
- TNGX $10.50
- LINC $24.00
- AVG Volume (30 Days)
- TNGX 1.9M
- LINC 169.0K
- Earning Date
- TNGX 08-05-2025
- LINC 08-11-2025
- Dividend Yield
- TNGX N/A
- LINC N/A
- EPS Growth
- TNGX N/A
- LINC N/A
- EPS
- TNGX N/A
- LINC 0.39
- Revenue
- TNGX $40,990,000.00
- LINC $454,204,000.00
- Revenue This Year
- TNGX N/A
- LINC $13.59
- Revenue Next Year
- TNGX N/A
- LINC $8.08
- P/E Ratio
- TNGX N/A
- LINC $59.42
- Revenue Growth
- TNGX 10.09
- LINC 15.24
- 52 Week Low
- TNGX $1.03
- LINC $11.22
- 52 Week High
- TNGX $12.02
- LINC $24.20
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- LINC 55.81
- Support Level
- TNGX $6.36
- LINC $22.26
- Resistance Level
- TNGX $7.11
- LINC $22.96
- Average True Range (ATR)
- TNGX 0.52
- LINC 0.68
- MACD
- TNGX -0.13
- LINC -0.01
- Stochastic Oscillator
- TNGX 53.15
- LINC 81.46
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.